Answers are grounded in this paper and cite their sources.
Conceptual framework highlights the integration of bioethics and implementation science in precision oncology, suggesting a joint strategy across the translational pipeline.
As technological and genomic innovations continue to advance precision cancer prevention, psychosocial, ethical, and operational complexities increasingly accompany their development. Addressing these challenges will require intentional cross-disciplinary collaboration. We argue that the distinct yet complementary lenses of bioethics and implementation science will be crucial as precision cancer prevention technologies move toward clinical integration. We provide a framework for how this joint effort can be accomplished and sustained across the translational pipeline.
No takes yet. Share an insight, caveat, or question.
Wicker et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: